Form 4: Recursion Pharmaceuticals Director Acquires Shares Under Compensation Policy

Blake Borgeson, a director at Recursion Pharmaceuticals, acquired 2,026 shares of Class A Common Stock on October 1, 2024, under the company's Outside Director Compensation Policy.

Summary

• On October 1, 2024, Blake Borgeson, a director of Recursion Pharmaceuticals, acquired 2,026 shares of Class A Common Stock.
• The acquisition was made under the Issuer's Outside Director Compensation Policy.
• Following the transaction, Borgeson directly owns 7,100,454 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director increasing their stake in the company, which can be seen as a sign of confidence. However, it's a routine transaction under a compensation policy.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.

Future Outlook

The document does not contain any specific forward-looking statements.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake.

Key Dates